Cargando…
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
Monoclonal antibodies (mAbs), the new revolutionary class of medications, are fast becoming tools against various diseases thanks to a unique structure and function that allow them to bind highly specific targets or receptors. These specialized proteins can be produced in large quantities via the hy...
Autores principales: | Mokhtary, Pardis, Pourhashem, Zeinab, Mehrizi, Akram Abouei, Sala, Claudia, Rappuoli, Rino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405509/ https://www.ncbi.nlm.nih.gov/pubmed/36009408 http://dx.doi.org/10.3390/biomedicines10081861 |
Ejemplares similares
-
Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions
por: Vacca, Fabiola, et al.
Publicado: (2022) -
High-throughput bactericidal assays for monoclonal antibody screening against antimicrobial resistant Neisseria gonorrhoeae
por: Stazzoni, Samuele, et al.
Publicado: (2023) -
A new dawn for monoclonal antibodies against antimicrobial resistant bacteria
por: Troisi, Marco, et al.
Publicado: (2022) -
Is the single variant form of Plasmodium vivax Duffy binding protein-II (PvDBP-II) adequate for inclusion in a PvDBP-II-based vaccine?
por: Valizadeh, Vahideh, et al.
Publicado: (2014) -
Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease — current advances and challenges
por: Rappuoli, Rino, et al.
Publicado: (2017)